Antipsychotics NewsLatest News On Antipsychotics Risk Monitoring for Early Psychosis: First Steps1/30/2025 11:27 AM New Guidance Recommends Metformin to Prevent Antipsychotic Weight Gain12/20/2024 7:32 AM Finally, a New Option for Posttraumatic Stress Disorder?12/20/2024 5:14 AM Despite Risks, Antipsychotic Polypharmacy on the Rise11/26/2024 7:48 AM rTMS May Alleviate Common, Resistant Schizophrenia Symptoms11/25/2024 8:35 AM Eliminate Clozapine REMS, FDA Panels Say11/20/2024 2:32 PM Integrated Neuro, Primary Care Reduces Rates of Potentially Dangerous Rx Among Dementia Patients11/20/2024 6:36 AM Racial Inequities in Antipsychotic Prescribing11/12/2024 10:38 AM Most Benefit, Least Cost: Choosing the Right Antipsychotic10/31/2024 4:21 AM Pimavanserin a Better Option for Parkinson's Psychosis?10/10/2024 5:21 AM FDA OKs First-in-Class Antipsychotic for Schizophrenia9/27/2024 8:37 AM Antipsychotic Tapering in FEP Beneficial in the Long-term9/27/2024 4:14 AM Menopausal Hormone Therapy May Prevent Psychosis Relapse9/25/2024 6:35 AM Will 'Game-Changer' Antipsychotic Live Up to the Hype?9/20/2024 9:49 AM Antipsychotics Tied to Severe Respiratory Infection Risk9/17/2024 10:33 AM Undiagnosed, Untreated Tardive Dyskinesia, Hinders Adherence to Antipsychotics7/29/2024 10:11 AM Tardive Dyskinesia: 5 Things to Know7/12/2024 2:38 PM Managing Agitation in Alzheimer's Disease: 5 Things to Know7/10/2024 6:42 AM Early In-Hospital Long-Acting Injectable Antipsychotics for Schizophrenia Tied to Lower Readmission Risk7/5/2024 4:50 AM Specific Antipsychotics Linked to Increased Pneumonia Risk7/5/2024 4:42 AM
